(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,
6-diamino-2-[(2S,3R,4S,5R)-3,
4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]
oxyoxane-3,4-diol (Molecular Formula: C₁₇H₃₄N₄O₁₀)

Product Name:	(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4, 6-diamino-2-[(2S,3R,4S,5R)-3, 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl] oxyoxane-3,4-diol
CAS Registry Number:	25546-65-0
EINECS:	247-091-5
Synonyms:	Hetangmycin; Ribostamycine; SF 733; Ribostamycinum; Xylostatin; Dekamycin IV;Vistamycin; Ribastamin; Ribostamicina;(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4, 6-diamino-2-[(2S,3R,4S,5R)-3, 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl] oxyoxane-3,4-diol;
Molecular Structure:
Molecular Formula:	C₁₇H₃₄N₄O₁₀
Molecular Weight:	454.47266
Flash Point:
Refractive index:	1.662
Risk Codes:	61-20/21/22
Safety Statements:	Poison by intravenous route. Moderately toxic by intramuscular and intraperitoneal routes. Mildly toxic by ingestion. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.

(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol (Molecular Formula: C17H34N4O10)